Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,158,688 | 2,083,858 | 1,588,691 | 1,770,701 | 1,400,849 |
| Marketable Securities | 1,926,514 | 1,934,792 | 2,046,861 | 1,766,090 | 1,760,230 |
| Receivables | 718,304 | 793,072 | 703,325 | 531,297 | 857,105 |
| Inventories | 8,276 | 10,220 | 7,451 | N/A | N/A |
| Other current assets | 0 | 0 | 1 | -1 | -1 |
| TOTAL | $4,811,783 | $4,821,942 | $4,346,329 | $4,068,087 | $4,018,183 |
| Non-Current Assets | |||||
| PPE Net | 138,666 | 137,678 | 132,659 | 123,350 | 113,138 |
| Investments And Advances | 19,457 | 22,776 | 26,736 | 20,174 | 18,833 |
| Intangibles | 14,665 | 16,790 | 18,847 | 19,021 | 20,674 |
| Other Non-Current Assets | 139,392 | 145,562 | 147,415 | 149,144 | 116,537 |
| TOTAL | $312,180 | $322,806 | $325,657 | $311,688 | $269,182 |
| Total Assets | $5,123,963 | $5,144,748 | $4,671,986 | $4,379,775 | $4,287,365 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 334,976 | 341,786 | 274,376 | 264,135 | 242,986 |
| TOTAL | $360,677 | $423,692 | $291,177 | $281,716 | $258,137 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,792 | 4,818 | 4,821 | 4,755 | 4,673 |
| Other Non-Current Liabilities | 103,818 | 108,624 | 109,575 | 110,813 | 75,614 |
| TOTAL | $173,514 | $178,704 | $179,703 | $179,981 | $143,582 |
| Total Liabilities | $534,191 | $602,396 | $470,880 | $461,696 | $401,719 |
| Shareholders' Equity | |||||
| Common Shares | 9,583 | 9,636 | 9,643 | 9,511 | 9,346 |
| Retained earnings | 2,762,140 | 2,693,992 | 2,361,707 | 2,113,371 | 2,119,469 |
| Other shareholders' equity | 8,712 | 20,732 | 16,362 | 16,859 | 13,877 |
| TOTAL | $4,589,772 | $4,542,352 | $4,201,105 | $3,918,079 | $3,885,646 |
| Total Liabilities And Equity | $5,123,963 | $5,144,748 | $4,671,985 | $4,379,775 | $4,287,365 |